187 related articles for article (PubMed ID: 2155064)
1. Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer.
Bishop JF; Kefford R; Raghavan D; Zalcberg J; Stuart-Harris R; Ball D; Olver IN; Friedlander M; Bull C; Yuen K
Cancer Chemother Pharmacol; 1990; 25(5):367-70. PubMed ID: 2155064
[TBL] [Abstract][Full Text] [Related]
2. Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.
Bishop JF; Raghavan D; Stuart-Harris R; Morstyn G; Aroney R; Kefford R; Yuen K; Lee J; Gianoutsos P; Olver IN
J Clin Oncol; 1987 Oct; 5(10):1574-8. PubMed ID: 2821197
[TBL] [Abstract][Full Text] [Related]
3. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
Smith IE; Perren TJ; Ashley SA; Woodiwiss J; Forgeson GV; Yarnold JR; Ford HT
J Clin Oncol; 1990 May; 8(5):899-905. PubMed ID: 2159056
[TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin in small cell lung cancer.
Thatcher N; Lind M
Semin Oncol; 1990 Feb; 17(1 Suppl 2):40-8. PubMed ID: 2154859
[TBL] [Abstract][Full Text] [Related]
8. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study.
Collins C; Higano CS; Livingston RB; Griffin BR; Keppen MD; Miller TP
Cancer Chemother Pharmacol; 1989; 24(2):128-32. PubMed ID: 2543513
[TBL] [Abstract][Full Text] [Related]
11. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
[TBL] [Abstract][Full Text] [Related]
12. Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus.
Thatcher N; Lind M; Stout R; Payne C; Carroll KB; Campbell C; Moussalli H
Br J Cancer; 1989 Jul; 60(1):98-101. PubMed ID: 2553090
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin and etoposide (CarE) combined with radiotherapy and vincristine, doxorubicin and cyclophosphamide (VAC) in limited small cell lung cancer. A phase II study.
Virén M; Liippo K; Ojala A; Helle L; Jakobson M; Järvinen M; Paloheimo S; Salomaa ER; Salmi R; Nikkanen V
Acta Oncol; 1992; 31(7):761-5. PubMed ID: 1335738
[TBL] [Abstract][Full Text] [Related]
14. Limited small cell lung cancer: the effect of radiotherapy on local control following response to chemotherapy.
Ngan S; Ball D; Bull C; Bishop J; Duval P; Laidlaw C; Matthews J
Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):459-62. PubMed ID: 1648046
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
Hainsworth JD; Stroup SL; Greco FA
Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693
[TBL] [Abstract][Full Text] [Related]
16. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group.
Hong WK; Nicaise C; Lawson R; Maroun JA; Comis R; Speer J; Luedke D; Hurtubise M; Lanzotti V; Goodlow J
J Clin Oncol; 1989 Apr; 7(4):450-6. PubMed ID: 2538577
[TBL] [Abstract][Full Text] [Related]
17. Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung.
Shaw EG; Frytak S; Eagan RT; Richardson RL; Creagan ET; Jett JR; Foote RL; Su JQ; Schaid DJ; Lee RE
Am J Clin Oncol; 1996 Apr; 19(2):154-8. PubMed ID: 8610640
[TBL] [Abstract][Full Text] [Related]
18. Carboplatin/etoposide/vincristine therapy in small cell lung cancer.
Gatzemeier U; von Pawel J; Laumen R; Hossfeld DK; Neuhauss R; Reck M; Lenaz L
Oncology; 1992; 49 Suppl 1():25-33. PubMed ID: 1323809
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin in small cell lung cancer.
Gatzemeier U; Hossfeld DK; Neuhauss R; Reck M; Achterrath W; Lenaz L
Semin Oncol; 1991 Feb; 18(1 Suppl 2):8-16. PubMed ID: 1846981
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
Hainsworth JD; Gray JR; Stroup SL; Kalman LA; Patten JE; Hopkins LG; Thomas M; Greco FA
J Clin Oncol; 1997 Dec; 15(12):3464-70. PubMed ID: 9396399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]